| Patrick Fluck, | |
|
2101 N Waldron St, Hutchinson, KS 67502-1131 | |
| (620) 669-2500 | |
| (620) 694-2062 |
| Full Name | Patrick Fluck |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 28 Years |
| Location | 2101 N Waldron St, Hutchinson, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659341394 | NPI | - | NPPES |
| 200256650 A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 04-27025 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dialysis Center Of Hutchinson | Hutchinson, KS | Dialysis facility |
| Hutchinson Regional Medical Center Inc | Hutchinson, KS | Hospital |
| Mcpherson Hospital | Mcpherson, KS | Hospital |
| Pratt Regional Medical Center | Pratt, KS | Hospital |
| Hospital District #1 Of Rice County | Lyons, KS | Hospital |
| Kingman Community Hospital | Kingman, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hutchinson Clinic P A Inc | 5597658492 | 108 |
News Archive
Permanent lung damage caused by chronic obstructive pulmonary disease starts much earlier than previously thought, even before patients are showing symptoms.
The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.
A significant number of adults are at risk of unintentionally overdosing on over-the-counter (OTC) pain medication, according to a new study in the US by Dr. Michael Wolf, from Northwestern University in Chicago, and his colleagues. Their work¹, looking at the prevalence and potential misuse of pain medication containing the active ingredient acetaminophen as well as the likelihood of overdosing, appears online in the Journal of General Internal Medicine², published by Springer.
Children treated for obesity in primary or outpatient care have a relatively good chance of fending off weight problems over the next few years as well, a study published in Acta Paediatrica shows.
A case study published in the August issue of the journal CHEST found lenalidomide treatments may have an immediate effect in the treatment of sarcoidosis-related symptoms. Sarcoidosis, a disease that involves abnormal collections of inflammatory cells that can form nodules in various organs, can affect individuals from all racial and age groups.
› Verified 3 days ago
| Entity Name | Hutchinson Clinic P A Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043298474 PECOS PAC ID: 5597658492 Enrollment ID: O20040204000969 |
News Archive
Permanent lung damage caused by chronic obstructive pulmonary disease starts much earlier than previously thought, even before patients are showing symptoms.
The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.
A significant number of adults are at risk of unintentionally overdosing on over-the-counter (OTC) pain medication, according to a new study in the US by Dr. Michael Wolf, from Northwestern University in Chicago, and his colleagues. Their work¹, looking at the prevalence and potential misuse of pain medication containing the active ingredient acetaminophen as well as the likelihood of overdosing, appears online in the Journal of General Internal Medicine², published by Springer.
Children treated for obesity in primary or outpatient care have a relatively good chance of fending off weight problems over the next few years as well, a study published in Acta Paediatrica shows.
A case study published in the August issue of the journal CHEST found lenalidomide treatments may have an immediate effect in the treatment of sarcoidosis-related symptoms. Sarcoidosis, a disease that involves abnormal collections of inflammatory cells that can form nodules in various organs, can affect individuals from all racial and age groups.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick Fluck, 2101 N Waldron St, Hutchinson, KS 67502-1131 Ph: (620) 669-2500 | Patrick Fluck, 2101 N Waldron St, Hutchinson, KS 67502-1131 Ph: (620) 669-2500 |
News Archive
Permanent lung damage caused by chronic obstructive pulmonary disease starts much earlier than previously thought, even before patients are showing symptoms.
The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.
A significant number of adults are at risk of unintentionally overdosing on over-the-counter (OTC) pain medication, according to a new study in the US by Dr. Michael Wolf, from Northwestern University in Chicago, and his colleagues. Their work¹, looking at the prevalence and potential misuse of pain medication containing the active ingredient acetaminophen as well as the likelihood of overdosing, appears online in the Journal of General Internal Medicine², published by Springer.
Children treated for obesity in primary or outpatient care have a relatively good chance of fending off weight problems over the next few years as well, a study published in Acta Paediatrica shows.
A case study published in the August issue of the journal CHEST found lenalidomide treatments may have an immediate effect in the treatment of sarcoidosis-related symptoms. Sarcoidosis, a disease that involves abnormal collections of inflammatory cells that can form nodules in various organs, can affect individuals from all racial and age groups.
› Verified 3 days ago
Moh'd Al-halawani, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1701 E 23rd Ave, Hutchinson, KS 67502 Phone: 620-513-4800 | |
Naveed Salahuddin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 | |
Fadi Estephan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 Fax: 620-694-2037 | |
Kristin Constance, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2100 N Waldron St Ste 5, Hutchinson, KS 67502 Phone: 620-728-1498 Fax: 620-728-1838 | |
Michael Scott Green, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-694-4194 Fax: 620-694-2128 | |
Thoutireddy Krishna Reddy, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 Fax: 620-669-2501 | |
Humayun Ashraf, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 Fax: 620-694-2076 |